The First Sleep Apnea Drug Is Here

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea. In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists … Source